TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next
New York, January 9, 2026, 15:59 (EST) — Regular session TG Therapeutics (TGTX.O) shares fell about 7% on Friday, reversing an early rise and leaving the biotech near its session low. The stock was down 7% at $28.35 by 3:55 p.m. EST after opening at $30.69 and sliding as low as $28.215. It hit $30.83 earlier in the session. The move comes with the J.P. Morgan Healthcare Conference set to kick off on Monday in San Francisco, a meeting that often pulls in fresh corporate updates and deal chatter in one tight week. The bank’s agenda shows the event runs